Trial Projects

Study Design The study included a lenalidomide cohort and a background cohort. Patients in both cohorts had received ≥ 1 prior antimyeloma therapy and were required to have never received lenalidomide. Enrolled patients who were treated on the study with lenalidomide for off-label indications were kept in the study. To achieve a patient population reflective of those treated in real-world clinical practice, there were few restrictions on eligibility. Exclusion criteria were refusal to participate ...